BMO Capital Reiterates Market Perform Rating on Ionis Pharmaceuticals (IONS)

September 23, 2026 8:56 AM

BMO Capital analyst David Lebowitz reiterated a Market Perform rating and $54.00 price target on Ionis Pharmaceuticals (NASDAQ: IONS).The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found